Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CAPLYTA safely and effectively. See full prescribing information for CAPLYTA. CAPLYTA® (lumateperone) capsules, for oral use Initial U.S. Approval: 2019
Medication labelWhy this: Advisory · dailymed-prescription
CAPLYTA is indicated for: Treatment of schizophrenia in adults [see Clinical Studies (14.1)]. Treatment of depressive episodes associated with bipolar I or II disorder (bipolar depression) in adults, as monotherapy and as adjunctive therapy with lithium or valproate [see Clinical Studies (14.2)]. Adjunctive therapy with antidepressants for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies ( 14.3 ) ].
- generic_name
- lumateperone
- product_names
- lumateperone
- ndc
- 72060-142, 72060-142-40, 72060-142-07, 72060-121, 72060-121-40, 72060-121-07, 72060-110, 72060-110-40, 72060-110-07
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en